Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Norina, Tanaka"'
Publikováno v:
Journal of Immunology Research, Vol 2024 (2024)
Multiple myeloma (MM) is an intractable hematological malignancy caused by abnormalities in plasma cells. Combination therapy using antibodies and natural killer (NK) effectors, which are innate immune cells with safe and potent antitumor activity, i
Externí odkaz:
https://doaj.org/article/27e2c552273445f5b7a6b045d6e6e965
Autor:
Junji Tanaka, Norina Tanaka, Yan-Hua Wang, Kenjiro Mitsuhashi, Michiko Ryuzaki, Yuki Iizuka, Aya Watanabe, Midori Ishiyama, Akihito Shinohara, Hiroshi Kazama, Shotaro Hagiwara, Kentaro Yoshinaga, Yumi Kougen, Hirohito Kobayashi, Hitoshi Kanno, Masayuki Shiseki
Publikováno v:
Haematologica, Vol 105, Iss 4 (2020)
Externí odkaz:
https://doaj.org/article/217b9b5923bc4608a54b1490e400b057
Autor:
Hideto Tamura, Koiti Inokuchi, Hiroki Sugimori, Takeshi Odajima, Junji Tanaka, Norio Komatsu, Keiichi Moriya, Asaka Onodera, Yasuko Kuribayashi-Hamada, Yuta Kaito, Mika Sunakawa, Toshio Asayama, Shigeki Ito, Sakae Tanosaki, Yutaka Tsukune, Norina Tanaka, Yoichi Imai, Hiroshi Handa, Makoto Sasaki, Asako Tsubota, Risa Takahashi, Mariko Ishibashi
Table S1. Primer sequences Table S2. Patient characteristics in cell - surface SLAMF3 and CD138 expression analysis. Table S3. One hundred and sixty-eight gene sets that were significantly upregulated in SLAMF3-KMS34 cells compared with Î"SLAMF3 cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1760c121042202d5de50c257c0692d93
https://doi.org/10.1158/1541-7786.22514517.v1
https://doi.org/10.1158/1541-7786.22514517.v1
Autor:
Shotaro Hagiwara, Masayuki Shiseki, Akihito Shinohara, Yuki Izuka, Junji Tanaka, Kentaro Yoshinaga, Aya Watanabe, Michiko Ryuzaki, Norina Tanaka, Midori Ishiyama
Publikováno v:
Acta Haematologica. 145:193-200
To evaluate the long-term efficacy of high-dose dexamethasone (HD-DXM) treatment for immune thrombocytopenia (ITP), we retrospectively analysed 36 newly diagnosed ITP patients treated with HD-DXM as a first-line treatment. An initial response was obt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a3eb55073603e486004e2afd955769c6
https://doi.org/10.1159/000518744
https://doi.org/10.1159/000518744
Autor:
Satoko Osanai, Akihito Shinohara, Maya Kobayashi, Michiko Ryuzaki, Midori Ishiyama, Junji Tanaka, Norina Tanaka, Shoko Oshima, Kentaro Yoshinaga, Yuki Izuka, Masayuki Shiseki, Megumi Oishi, Hiroshi Kazama, Shotaro Hagiwara, Aya Watanabe
Publikováno v:
Internal Medicine
We herein report two cases of thrombotic thrombocytopenic purpura (TTP) complicated by other autoimmune disorders, autoimmune hepatitis and immune thrombocytopenia, respectively. In both cases, corticosteroids were continuously administered for the t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b81ff5aa852f6fbe038256c553194683
https://doi.org/10.2169/internalmedicine.6387-20
https://doi.org/10.2169/internalmedicine.6387-20
Autor:
Tadao Ishida, Arinobu Tojo, Norio Komatsu, Hideto Tamura, Junya Makiyama, Norina Tanaka, Masahiro Kizaki, Hiroshi Yasui, Yoichi Imai, Yutaka Tsukune, Junji Tanaka, Kota Sato, Kazuaki Yokoyama, Kanya Kondoh, Hiroshi Handa, Yuta Kaito, Seiya Imoto, Makoto Sasaki, Masayuki Kobayashi, Toyotaka Kawamata
Publikováno v:
International Journal of Clinical Oncology. 26:2142-2150
Multiple myeloma (MM) is an incurable hematological malignancy. Despite the introduction of several novel drugs, most patients relapse. Biomarkers to identify the early signs of relapse will make it possible to adjust the therapeutic strategy before
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d549ecda24d4f1c25c220cc2bdecdcc
https://doi.org/10.1007/s10147-021-01991-z
https://doi.org/10.1007/s10147-021-01991-z
Autor:
Ryosuke Kinoshita, Mariko Ishibashi, Hiroshi Handa, Makoto Sasaki, Yoichi Imai, Norina Tanaka, Shigeki Ito, Mika Sunakawa-Kii, Yuta Kaito, Toshio Asayama, Norio Komatsu, Junji Tanaka, Takeshi Odajima, Hiroki Sugimori, Hiroki Yamaguchi, Koiti Inokuchi, Hideto Tamura
Publikováno v:
Experimental Hematology. 121:38-47.e2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::64446e37d71657cddd4c597894a3d0ff
https://doi.org/10.1016/j.exphem.2023.01.006
https://doi.org/10.1016/j.exphem.2023.01.006
Publikováno v:
Annals of Hematology. 99:2577-2586
Although treatment outcomes for diffuse large B cell lymphoma (DLBCL) have improved with the introduction of rituximab, approximately half of patients experience relapsed/refractory (r/r) disease. Furthermore, no standard salvage therapy has yet been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41b4bdf10096feccafa000a6937434ce
https://doi.org/10.1007/s00277-020-04267-0
https://doi.org/10.1007/s00277-020-04267-0
Publikováno v:
International Journal of Dermatology. 61
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b01718933744c008e647eeb8b30cd40a
https://doi.org/10.1111/ijd.15956
https://doi.org/10.1111/ijd.15956
Autor:
Yan-Hua Wang, Junji Tanaka, Masayuki Shiseki, Mayuko Ishii, Satoko Osanai, Mari Ohwashi, Norina Tanaka, Naoki Mori, Kentaro Yoshinaga
Publikováno v:
Leukemialymphoma. 62(10)
We investigated the clinical implications of preferentially expressed antigen in melanoma (PRAME) expression in bone marrow cells of 116 patients with myelodysplastic syndromes (MDS). Quantitative ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b9bbacb2d7a55497706bf3d90a7c50e
https://pubmed.ncbi.nlm.nih.gov/34013846
https://pubmed.ncbi.nlm.nih.gov/34013846